LIVIVO - Search results -

Search results

Result 1 - 10 of total 933

Search options

Article: Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases.

Waldecker-Gall, Sabina / Seibert, Felix / Bertram, Sebastian / Doevelaar, Adrian / Braun, Jürgen / Baraliakos, Xenofon / Babel, Nina / Waldecker, Christoph / Scharow, Linda / Pagonas, Nikolaos / Westhoff, Timm H

Therapeutic advances in musculoskeletal disease

2023 Volume 15, Page(s) 1759720X231187191

Abstract: ... the functionality of high-density lipoprotein (HDL), for example, by oxidative processes.: Objectives: Assessment ...

Abstract	Background: The mechanism explaining low cholesterol concentrations in chronic inflammatory rheumatic disease (CIRD) is incompletely understood. We hypothesized that chronic inflammation impairs the functionality of high-density lipoprotein (HDL), for example, by oxidative processes. Objectives: Assessment of oxidized HDL (HDL Design: Prospective observational trial. Methods: The study was conducted on 44 newly diagnosed CIRD patients, who were initiated on immunosuppressive therapy (baseline). A total of 136 patients without CIRD served as control. Lipid profiles including HDL Results: A total of 33 (75%) patients with rheumatoid arthritis, 7(16%) with axial spondyloarthritis, and 4 (9%) with systemic lupus erythematosus were included. Groups were comparable for age and BMI. CIRD patients had higher HDL Conclusion: CIRD is associated with an impairment of the anti-inflammatory properties of HDL as reflected by an increase in HDL
Language	English
Publishing date	2023-08-25
Publishing country	England
Document type	Journal Article
ZDB-ID	2516075-8
ISSN	1759-7218 ; 1759-720X
ISSN (online)	1759-7218
ISSN	1759-720X
DOI	10.1177/1759720X231187191
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Adipose tissue dysfunction serum markers are associated with high density lipoprotein size and glycation in the early stages of type 2 diabetes.

Jorge-Galarza, Esteban / Medina-Urrutia, Aida / Reyes-Barrera, Juan / Torres-Tamayo, Margarita / Montaño-Estrada, Luis Felipe / Páez-Arenas, Araceli / Massó-Rojas, Felipe / Juárez-Rojas, Juan Gabriel

Lipids in health and disease

2023 Volume 22, Issue 1, Page(s) 89

Abstract: Background: High-density lipoproteins (HDLs) have antiatherogenic properties related ... and free fatty acids (FFAs) and high sensitivity C-reactive protein (hs-CRP) were determined ... levels. However, whether AT dysfunction affects HDL subpopulations and their glycation in early type 2 ...

Abstract	Background: High-density lipoproteins (HDLs) have antiatherogenic properties related to their chemical structure. Adipose tissue (AT) influences HDL reverse cholesterol transport and plasma HDL cholesterol levels. However, whether AT dysfunction affects HDL subpopulations and their glycation in early type 2 diabetes (T2D) is still unknown. Objective: To investigate the association of inflammation and AT dysfunction serum markers with the size and glycation of HDLs in normoglycemic, prediabetes, and T2D subjects. Methods: We assessed HDL particle size and advanced glycation end-product (AGE) content in HDLs isolated from normoglycemic (n = 17), prediabetes (n = 17), and recently T2D-diagnosed (n = 18) subjects. Insulin, adiponectin, and plasminogen activator inhibitor 1 (PAI-1) were determined using the Bio-Rad Multiplex Platform, and free fatty acids (FFAs) and high sensitivity C-reactive protein (hs-CRP) were determined by standard procedures. The AT insulin resistance (ATIR) index and ATIR/adiponectin and adiponectin/leptin ratios were calculated. Results: HDL was progressively smaller (nm) and enriched with AGE (mg-BSA-AGE/mg protein) according to the glucose categories: 8.49 and 7.5 in normoglycemic subjects, 8.44 and 12.4 in prediabetic subjects, and 8.32 and 14.3 in T2D subjects (P = 0.033 and P = 0.009 for size and AGE, respectively). In multivariable regression analysis, the ATIR/adiponectin ratio was inversely associated with HDL size (β = -0.257, P = 0.046), and the ATIR ratio was directly associated with HDL glycation (β = 0.387, P = 0.036). In contrast, adiponectin and the adiponectin/leptin ratio were not associated with alterations in HDL particles. Furthermore, HDL size was associated with resistin (β = -0.348, P = 0.007) and PAI-1 (β = -0.324, P = 0.004). HDL and AGE were related to insulin concentrations (β = 0.458, P = 0.015). Analyses were adjusted for age, sex, body mass index, triglycerides, and HDL-cholesterol. Conclusion: HDL size was significantly associated with the ATIR/adiponectin ratio and inflammation, whereas glycation was more strongly related to the ATIR index. These findings have important implications for the management and prevention of cardiovascular disease in T2D patients.
MeSH term(s)	Humans ; Leptin ; Maillard Reaction ; Diabetes Mellitus, Type 2 ; Lipoproteins, HDL ; Plasminogen Activator Inhibitor 1 ; Prediabetic State ; Adiponectin ; Adipose Tissue ; Glycation End Products, Advanced ; Cholesterol, HDL ; Insulin ; Biomarkers
Chemical Substances	Leptin ; Lipoproteins, HDL ; Plasminogen Activator Inhibitor 1 ; Adiponectin ; Glycation End Products, Advanced ; Cholesterol, HDL ; Insulin ; Biomarkers
Language	English
Publishing date	2023-07-01
Publishing country	England
Document type	Journal Article
ZDB-ID	2091381-3
ISSN	1476-511X ; 1476-511X
ISSN (online)	1476-511X
ISSN	1476-511X
DOI	10.1186/s12944-023-01847-7
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Conference proceedings: Dysfunctional high-density Lipoprotein in chronic inflammatory rheumatic diseases

Waldecker-Gall, Sabina / Seibert, Felix Sebastian / Bertram, Sebastian / Doevelaar, Adrian / Babel, Nina / Waldecker, Christoph / Braun, Jürgen / Baraliakos, Xenofon / Scharow, Linda / Pagonas, Nikolaos / Westhoff, Timm Henning

2023 , Page(s) ET.02

Event/congress	Deutscher Rheumatologiekongress 2023, 51. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 37. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), 33. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR); Leipzig; ; Gesellschaft für Kinder- und Jugendrheumatologie; 2023
Keywords	Medizin, Gesundheit
Publishing date	2023-08-30
Publisher	German Medical Science GMS Publishing House; Düsseldorf
Document type	Conference proceedings
DOI	10.3205/23dgrh022
Database	German Medical Science

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article: High-density lipoprotein dysfunction in carotid artery stenosis.

Senat, Almila / Ilker Yon, Mehmet / Yuce, Gokhan / Deniz, Orhan / Erel, Ozcan

VASA. Zeitschrift fur Gefasskrankheiten

2023 Volume 52, Issue 5, Page(s) 342–348

MeSH term(s)	Humans ; Carotid Stenosis/complications ; Carotid Stenosis/diagnostic imaging ; Constriction, Pathologic ; Aryldialkylphosphatase ; Lipid Peroxides ; Lipoproteins, HDL
Chemical Substances	Aryldialkylphosphatase (EC 3.1.8.1) ; Lipid Peroxides ; Lipoproteins, HDL ; PON1 protein, human (EC 3.1.8.1)
Language	English
Publishing date	2023-08-25
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	120977-2
ISSN	1664-2872 ; 0301-1526
ISSN (online)	1664-2872
ISSN	0301-1526
DOI	10.1024/0301-1526/a001082
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 808: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality.

Shih, Chun-Ming / Lin, Feng-Yen / Yeh, Jong-Shiuan / Lin, Yi-Wen / Loh, Shih-Hurng / Tsao, Nai-Wen / Nakagami, Hironori / Morishita, Ryuichi / Sawamura, Tatsuya / Li, Chi-Yuan / Lin, Cheng-Yen / Huang, Chun-Yao

Translational research : the journal of laboratory and clinical medicine

2018 Volume 205, Page(s) 17–32

Abstract: ... suggested that reduced high density lipoprotein (HDL) levels might be an important morbidity indicator ... the effect of HDL on oxidized low density lipoprotein (oxLDL)-stimulated endothelial progenitor cells (EPCs ...

Abstract	Lipid metabolic disorders play critical roles in atherogenesis. Traditionally, it has been suggested that reduced high density lipoprotein (HDL) levels might be an important morbidity indicator for cardiovascular diseases. Therefore, it has been argued that therapeutically raising HDL levels may reduce atherogenesis in patients with dyslipidemia. However, recent clinical trials to elevate serum HDL levels by pharmacologic approaches failed to demonstrate clinical efficacy. Thus, to investigate the functionality of HDL and to explore the possible clinical relevance as well as to define an effective indicator that can represent HDL function may provide another key and reference to disclose the clinical treatment of dyslipidemia. We analyzed the association between the data of dichlorofluorescein assay (assay the functionality of HDL), the effect of HDL on oxidized low density lipoprotein (oxLDL)-stimulated endothelial progenitor cells (EPCs) in vitro, levels of circulating EPCs, and ex vitro EPC colony forming units of each case, we defined the indicator (relative HDL index (RHDL index) = dichlorofluorescein assay result of each subject/dichlorofluorescein assay reading of our young healthy controls) that may represent functionality of HDL. HDL from healthy adults protected oxLDL-treated EPCs by modulating p38 mitogen-activated protein kinase and Rho activation and by promoting nitric oxide production. HDL from subject with RHDL index ≧2 also failed to restore the functionality of oxLDL-treated EPCs via cell-signaling pathways in vitro. The RHDL index significantly correlated with patients' circulating EPC number or EPC colony forming units ex vivo. In conclusions, we explored the RHDL index as a score to predict a patient's EPC functions in vivo and ex vitro.
MeSH term(s)	Adult ; Aged ; Dyslipidemias/blood ; Endothelial Progenitor Cells/drug effects ; Enzyme Activation ; Female ; Humans ; Lipoproteins, HDL/blood ; Lipoproteins, HDL/physiology ; Lipoproteins, LDL/blood ; Lipoproteins, LDL/pharmacology ; Lipoxygenase/metabolism ; Male ; Middle Aged ; Nitric Oxide/biosynthesis ; Signal Transduction ; p38 Mitogen-Activated Protein Kinases/metabolism ; rho-Associated Kinases/metabolism
Chemical Substances	Lipoproteins, HDL ; Lipoproteins, LDL ; oxidized low density lipoprotein ; Nitric Oxide (31C4KY9ESH) ; Lipoxygenase (EC 1.13.11.12) ; rho-Associated Kinases (EC 2.7.11.1) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24)
Language	English
Publishing date	2018-10-09
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2246684-8
ISSN	1878-1810 ; 1532-6543 ; 1931-5244
ISSN (online)	1878-1810 ; 1532-6543
ISSN	1931-5244
DOI	10.1016/j.trsl.2018.09.005
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ud II Zs 42: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: [Dysfunctional high-density lipoproteins in diabetes mellitus].

Poteryaeva, O N / Usynin, I F

Problemy endokrinologii

2022 Volume 68, Issue 4, Page(s) 69–77

Abstract: ... which includes abnormalities in all lipoproteins, including high-density lipoproteins (HDL). The development ... in their structure. This leads to the transformation of native HDL into so-called dysfunctional or diabetic HDL ...

Abstract	The risk of cardiovascular disease (CVD) in persons with type 2 diabetes mellitus (DM2) increases two to four times. One of the main factors increasing cardiovascular risk is dyslipidemia, which includes abnormalities in all lipoproteins, including high-density lipoproteins (HDL). The development of DM2 is accompanied not only by a decrease in the level of HDL, but also by significant changes in their structure. This leads to the transformation of native HDL into so-called dysfunctional or diabetic HDL, which loses their antiatherogenic, cardioprotective, anti-inflammatory and anti-diabetic properties. In poorly controlled diabetes mellitus HDL can not only lose its beneficial functions, but also acquire proatherogenic, proinflammatory ones. Diabetic HDL can contribute to the accumulation of such unfavorable qualities as increased proliferation, migration, and invasion of cancer cells. Given that HDL, in addition to participation in cholesterol transport, performs important regulatory functions in the body, there is reason to assume that structural modifications of HDL (oxidation, glycation, triglyceride enrichment, loss of HDL-associated enzymes, etc.) are one of the causes of vascular complications of diabetes.
MeSH term(s)	Cardiovascular Diseases ; Diabetes Mellitus, Type 2/complications ; Dyslipidemias/complications ; Humans ; Lipoproteins ; Lipoproteins, HDL
Chemical Substances	Lipoproteins ; Lipoproteins, HDL
Language	Russian
Publishing date	2022-06-10
Publishing country	Russia (Federation)
Document type	Journal Article
ZDB-ID	421785-8
ISSN	2308-1430 ; 2072-6406 ; 0032-9509 ; 0375-9660
ISSN (online)	2308-1430
ISSN	2072-6406 ; 0032-9509 ; 0375-9660
DOI	10.14341/probl13118
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 62: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 516: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Dysfunctional antioxidant capacity of high-density lipoprotein in rheumatoid arthritis.

García-Gómez, María Carmen / Padró, Teresa / Muñoz-García, Natàlia / Bianchi, María / Álvarez, Lorenzo / Badimon, Lina / Corbella, Emili / Pintó, Xavier

European journal of clinical investigation

2023 Volume 53, Issue 8, Page(s) e13999

Abstract: Background: High-density lipoprotein (HDL) presents atheroprotective functions not readily ... by the Conjugated Dienes Assay (D: Results: High-density lipoprotein from RA patients showed lower antioxidant ... potential test (TRAP-assay) and the susceptibility of low-density lipoprotein (LDL) to oxidation ...

Abstract	Background: High-density lipoprotein (HDL) presents atheroprotective functions not readily reflected by plasma HDL-cholesterol levels. The aim of this study was to investigate HDL antioxidant function in patients with rheumatoid arthritis (RA). Methods: This pilot and cross-sectional study included 50 RA patients and 50 controls matched by age, gender, cardiovascular risk factors and drug therapy. The antioxidant capacity of HDL was assessed by the total radical-trapping antioxidative potential test (TRAP-assay) and the susceptibility of low-density lipoprotein (LDL) to oxidation by the Conjugated Dienes Assay (D Results: High-density lipoprotein from RA patients showed lower antioxidant capacity than those from controls [oxidized-LDL%: 35.8 (27-42) vs. 24.4 (20-32), p < .001] when analysed with the TRAP-assay. In addition, the time to achieve 50% of maximal LDL oxidation (Lag-time) was shorter in RA-patients than in matched controls [57.2 (42-71) vs. 69.5 (55-75) minutes, (p = .003)]. RA patients showed a higher atherosclerotic burden than controls. The pro-oxidant pattern in RA was irrespective of the presence of carotid atherosclerosis. On the contrary, there was a positive correlation between inflammatory parameters (erythrocyte sedimentation rate, ultrasensitive C-reactive protein and fibrinogen) and the loss of HDL-anti-oxidant capacity measured by the TRAP-assay (rho = .211, p = .035; rho = .231, p = .021 and rho = .206, p = .041, respectively). Furthermore, the glucocorticoid dose at recruitment was negatively associated with the Lag-time in RA patients (rho = -.387, p = .026). Conclusion: Rheumatoid arthritis patients present reduced HDL antioxidant capacity and a lower resistance of LDL particles to oxidation, mainly related to the degree of inflammation.
MeSH term(s)	Humans ; Lipoproteins, HDL ; Antioxidants/therapeutic use ; Cross-Sectional Studies ; Arthritis, Rheumatoid/complications ; Lipoproteins, LDL ; Inflammation/complications ; Atherosclerosis/complications
Chemical Substances	Lipoproteins, HDL ; Antioxidants ; Lipoproteins, LDL
Language	English
Publishing date	2023-04-07
Publishing country	England
Document type	Journal Article
ZDB-ID	186196-7
ISSN	1365-2362 ; 0014-2972 ; 0960-135X
ISSN (online)	1365-2362
ISSN	0014-2972 ; 0960-135X
DOI	10.1111/eci.13999
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 677: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: High Density Lipoprotein and it's Dysfunction.

Eren, Esin / Yilmaz, Necat / Aydin, Ozgur

The open biochemistry journal

2012 Volume 6, Page(s) 78–93

Abstract: Plasma high-density lipoprotein cholesterol(HDL-C) levels do not predict functionality and ... composition of high-density lipoprotein(HDL). Traditionally, keeping levels ... of low-density lipoprotein cholesterol(LDL-C) down and HDL-C up have been the goal of patients to prevent atherosclerosis that can lead ...

Abstract	Plasma high-density lipoprotein cholesterol(HDL-C) levels do not predict functionality and composition of high-density lipoprotein(HDL). Traditionally, keeping levels of low-density lipoprotein cholesterol(LDL-C) down and HDL-C up have been the goal of patients to prevent atherosclerosis that can lead to coronary vascular disease(CVD). People think about the HDL present in their cholesterol test, but not about its functional capability. Up to 65% of cardiovascular death cannot be prevented by putative LDL-C lowering agents. It well explains the strong interest in HDL increasing strategies. However, recent studies have questioned the good in using drugs to increase level of HDL. While raising HDL is a theoretically attractive target, the optimal approach remains uncertain. The attention has turned to the quality, rather than the quantity, of HDL-C. An alternative to elevations in HDL involves strategies to enhance HDL functionality. The situation poses an opportunity for clinical chemists to take the lead in the development and validation of such biomarkers. The best known function of HDL is the capacity to promote cellular cholesterol efflux from peripheral cells and deliver cholesterol to the liver for excretion, thereby playing a key role in reverse cholesterol transport (RCT). The functions of HDL that have recently attracted attention include anti-inflammatory and anti-oxidant activities. High antioxidant and anti-inflammatory activities of HDL are associated with protection from CVD.This review addresses the current state of knowledge regarding assays of HDL functions and their relationship to CVD. HDL as a therapeutic target is the new frontier with huge potential for positive public health implications.
Language	English
Publishing date	2012-07-27
Publishing country	United Arab Emirates
Document type	Journal Article
ZDB-ID	2396170-3
ISSN	1874-091X ; 1874-091X
ISSN (online)	1874-091X
ISSN	1874-091X
DOI	10.2174/1874091X01206010078
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Anticipatory role of high density lipoprotein and endothelial dysfunction: an overview.

Eren, Esin / Yılmaz, Necat / Aydin, Ozgur / Ellidağ, Hamit Y

The open biochemistry journal

2014 Volume 8, Page(s) 100–106

Abstract: High Density Lipoprotein (HDL) has been witnessed to possess a range of different functions ...

Abstract	High Density Lipoprotein (HDL) has been witnessed to possess a range of different functions that contribute to its atheroprotective effects. These functions are: the promotion of macrophage cholesterol efflux, reverse cholesterol transport, anti-inflammatory, anti-thrombotic, anti-apoptotic, pro-fibrinolytic and anti-oxidative functions. Paraoxonase 1 (PON1) is an HDL associated enzyme esterase/homocysteinethiolactonase that contributes to the anti-oxidant and anti-atherosclerotic capabilities of HDL. PON1 is directly involved in the etiopathogenesis of atherosclerosis through the modulation of nitric oxide (NO) bioavailability. The aim of this review is to summarize the role of HDL on endothelial homeostasis, and also to describe the recently characterized molecular pathways involved.
Language	English
Publishing date	2014-12-31
Publishing country	United Arab Emirates
Document type	Journal Article
ZDB-ID	2396170-3
ISSN	1874-091X
ISSN	1874-091X
DOI	10.2174/1874091X01408010100
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Chronic kidney disease induced dysfunction of high density lipoprotein.

Yamamoto, Suguru / Kon, Valentina

Clinical and experimental nephrology

2013 Volume 18, Issue 2, Page(s) 251–254

Abstract: ... and thus have an exaggerated residual cardiovascular risk. High density lipoprotein (HDL) quantity and ...

Abstract	Traditional risk factors do not account for increased cardiovascular disease in patients with chronic kidney disease (CKD), particularly individuals whose CKD has progressed to end-stage kidney disease requiring dialysis. CKD patients on dialysis show little to no cardiovascular benefits from lipid-lowering therapy and thus have an exaggerated residual cardiovascular risk. High density lipoprotein (HDL) quantity and functionality may explain some of the residual risk. CKD affects the composition and disrupts the functionality of HDL, including cholesterol acceptor function and inflammatory effects. Notably, although these HDL abnormalities prevail in CKD, they do not track together and thereby support the idea of separate and distinct mechanistic pathways for each critical function of HDL. Targeting individual perturbations in HDL function represents a novel approach to therapy in this population.
MeSH term(s)	Cardiovascular Diseases/etiology ; Humans ; Lipoproteins, HDL/metabolism ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/physiopathology ; Risk Factors
Chemical Substances	Lipoproteins, HDL
Language	English
Publishing date	2013-09-10
Publishing country	Japan
Document type	Journal Article ; Review
ZDB-ID	1338768-6
ISSN	1437-7799 ; 1342-1751
ISSN (online)	1437-7799
ISSN	1342-1751
DOI	10.1007/s10157-013-0857-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4922: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito